Sequoia Capital India has invested $12 million in over-the-counter drug and cosmetic maker Paras Pharmaceuticals, bringing the Indian company’s total raised to $54 million in just the past two months, according to VentureWire (sub required).
In October, U.K.-based Actis Capital made a $42 million commitment to Paras citing a current boon in the pharmaceuticals industry in India and strong product placement of at least two of Para’s 15 brands. Based in Ahmedabad, India, Paras sells pharmaceutical and cosmeceutical products….
Trackback URL
